LONCASTUXIMAB TESIRINE

LONCASTUXIMAB TESIRINE was reported 410 times

These side effects are most commonly reported by patients taking LONCASTUXIMAB TESIRINE:

# Side effect Count
0 DEATH 69
1 DISEASE PROGRESSION 33
2 RASH 32
3 PLEURAL EFFUSION 24
4 FATIGUE 22
5 PHOTOSENSITIVITY REACTION 21
6 NEUTROPENIA 18
7 ANAEMIA 16
8 THROMBOCYTOPENIA 15
9 COVID-19 14
10 OEDEMA 14
11 OFF LABEL USE 14
12 PNEUMONIA 14
13 DIFFUSE LARGE B-CELL LYMPHOMA 13
14 OEDEMA PERIPHERAL 12
15 DRUG INEFFECTIVE 10
16 INFECTION 10
17 PANCYTOPENIA 10
18 FEBRILE NEUTROPENIA 9
19 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9
20 PERICARDIAL EFFUSION 9
21 PLATELET COUNT DECREASED 9
22 CYTOPENIA 8
23 DIARRHOEA 8
24 DYSPNOEA 8
25 SEPSIS 8
26 BLISTER 6
27 BONE MARROW FAILURE 6
28 CONDITION AGGRAVATED 6
29 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6
30 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 6
31 HEPATIC ENZYME INCREASED 6
32 HEPATOTOXICITY 6
33 MALIGNANT NEOPLASM PROGRESSION 6
34 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
35 NAUSEA 6
36 SKIN TOXICITY 6
37 DRUG INTOLERANCE 5
38 LEUKOPENIA 5
39 NEUTROPHIL COUNT DECREASED 5
40 PYREXIA 5
41 RENAL FAILURE 5
42 SEPTIC SHOCK 5
43 ACUTE KIDNEY INJURY 4
44 ALANINE AMINOTRANSFERASE INCREASED 4
45 ASCITES 4
46 ASTHENIA 4
47 ATRIAL FIBRILLATION 4
48 BLOOD ALKALINE PHOSPHATASE INCREASED 4
49 CARDIAC FAILURE HIGH OUTPUT 4
50 CARDIOTOXICITY 4
51 COUGH 4
52 CYTOKINE RELEASE SYNDROME 4
53 FUSARIUM INFECTION 4
54 HEADACHE 4
55 INTERSTITIAL LUNG DISEASE 4
56 NEOPLASM PROGRESSION 4
57 PRODUCT PREPARATION ERROR 4
58 PRURITUS 4
59 RASH MACULO-PAPULAR 4
60 URINARY TRACT INFECTION 4
61 CAPILLARY LEAK SYNDROME 3
62 CELLULITIS 3
63 DECREASED APPETITE 3
64 ERYTHEMA 3
65 GENERALISED OEDEMA 3
66 HAEMOGLOBIN DECREASED 3
67 HEPATIC FUNCTION ABNORMAL 3
68 HYPERVOLAEMIA 3
69 HYPOGAMMAGLOBULINAEMIA 3
70 HYPOXIA 3
71 INTERCEPTED MEDICATION ERROR 3
72 LIVER FUNCTION TEST INCREASED 3
73 LYMPHOMA 3
74 NEUROPATHY PERIPHERAL 3
75 PNEUMONIA BACTERIAL 3
76 PNEUMONITIS 3
77 PRODUCT STORAGE ERROR 3
78 PRODUCT TEMPERATURE EXCURSION ISSUE 3
79 RASH VESICULAR 3
80 RESPIRATORY FAILURE 3
81 SUNBURN 3
82 SWELLING FACE 3
83 UROSEPSIS 3
84 WEIGHT DECREASED 3
85 ABDOMINAL DISCOMFORT 2
86 ABDOMINAL DISTENSION 2
87 ABDOMINAL PAIN 2
88 ACUTE RESPIRATORY FAILURE 2
89 ANXIETY 2
90 ARTHROPOD BITE 2
91 ASPARTATE AMINOTRANSFERASE INCREASED 2
92 AUTOIMMUNE DISORDER 2
93 BILIARY OBSTRUCTION 2
94 BLOOD CREATININE INCREASED 2
95 BLOOD GLUCOSE DECREASED 2
96 BLOOD GLUCOSE INCREASED 2
97 BLOOD LACTATE DEHYDROGENASE INCREASED 2
98 CHRONIC KIDNEY DISEASE 2
99 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
100 CLOSTRIDIUM DIFFICILE INFECTION 2
101 CNS VENTRICULITIS 2
102 CONSTIPATION 2
103 CUTANEOUS COLLAGENOUS VASCULOPATHY 2
104 DEPRESSION 2
105 DYSPHAGIA 2
106 END STAGE RENAL DISEASE 2
107 ENTEROCOCCAL INFECTION 2
108 FAILURE TO THRIVE 2
109 GENERAL PHYSICAL HEALTH DETERIORATION 2
110 GRAFT VERSUS HOST DISEASE 2
111 HAEMATURIA 2
112 HYDROCEPHALUS 2
113 HYPERGLYCAEMIA 2
114 HYPERKALAEMIA 2
115 HYPERSENSITIVITY 2
116 HYPOTENSION 2
117 ILL-DEFINED DISORDER 2
118 ILLNESS 2
119 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2
120 LABORATORY TEST ABNORMAL 2
121 LYMPHOPENIA 2
122 MEDICATION ERROR 2
123 MENINGITIS PNEUMOCOCCAL 2
124 MENTAL DISORDER 2
125 METABOLIC ACIDOSIS 2
126 NAIL DISCOLOURATION 2
127 NO ADVERSE EVENT 2
128 NON-HODGKIN^S LYMPHOMA 2
129 PAIN 2
130 PAIN IN EXTREMITY 2
131 PERIORBITAL SWELLING 2
132 PERIPHERAL SWELLING 2
133 PRODUCT DISTRIBUTION ISSUE 2
134 PRODUCT PREPARATION ISSUE 2
135 PRODUCT USE ISSUE 2
136 RASH PRURITIC 2
137 RENAL IMPAIRMENT 2
138 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2
139 SKIN EXFOLIATION 2
140 SKIN HYPERTROPHY 2
141 SKIN ULCER 2
142 SLIPPING RIB SYNDROME 2
143 SWELLING 2
144 TUBULOINTERSTITIAL NEPHRITIS 2
145 TUMOUR LYSIS SYNDROME 2
146 UPPER RESPIRATORY TRACT INFECTION 2
147 VISION BLURRED 2
148 WEIGHT INCREASED 2
149 WHITE BLOOD CELL COUNT DECREASED 2
150 ABDOMINAL PAIN UPPER 1
151 ABNORMAL WEIGHT GAIN 1
152 ACCIDENTAL OVERDOSE 1
153 ACUTE RESPIRATORY DISTRESS SYNDROME 1
154 ACUTE SINUSITIS 1
155 ADVERSE EVENT 1
156 AGEUSIA 1
157 ALTERED STATE OF CONSCIOUSNESS 1
158 ANGIOPATHY 1
159 ASTERIXIS 1
160 AUTOIMMUNE HEPATITIS 1
161 B-CELL LYMPHOMA 1
162 B-LYMPHOCYTE COUNT DECREASED 1
163 BACK PAIN 1
164 BLINDNESS UNILATERAL 1
165 BLOOD BILIRUBIN INCREASED 1
166 BLOOD CULTURE POSITIVE 1
167 BLOOD LACTIC ACID INCREASED 1
168 BONE MARROW INFILTRATION 1
169 CAMPYLOBACTER INFECTION 1
170 CANDIDA INFECTION 1
171 CARDIAC FAILURE CONGESTIVE 1
172 CARDIAC TAMPONADE 1
173 CELL MARKER DECREASED 1
174 CHEST PAIN 1
175 CHOLESTASIS 1
176 CHRONIC RESPIRATORY FAILURE 1
177 COGNITIVE DISORDER 1
178 COLLAGEN-VASCULAR DISEASE 1
179 CORONAVIRUS INFECTION 1
180 COVID-19 PNEUMONIA 1
181 CREPITATIONS 1
182 CSF LYMPHOCYTE COUNT ABNORMAL 1
183 CYTOMEGALOVIRUS INFECTION 1
184 CYTOMEGALOVIRUS INFECTION REACTIVATION 1
185 DEHYDRATION 1
186 DELIRIUM 1
187 DEPRESSED LEVEL OF CONSCIOUSNESS 1
188 DERMATITIS 1
189 DERMATITIS ACNEIFORM 1
190 DERMATITIS BULLOUS 1
191 DERMATITIS EXFOLIATIVE GENERALISED 1
192 DEVICE LEAKAGE 1
193 DISEASE RECURRENCE 1
194 DIVERTICULUM INTESTINAL 1
195 DIZZINESS 1
196 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
197 DRUG INTERACTION 1
198 DRUG-INDUCED LIVER INJURY 1
199 DRY SKIN 1
200 DYSGEUSIA 1
201 EARLY SATIETY 1
202 ECZEMA 1
203 EFFUSION 1
204 EOSINOPHIL COUNT DECREASED 1
205 EYE DISORDER 1
206 EYE IRRITATION 1
207 EYE OEDEMA 1
208 EYELID OEDEMA 1
209 FACE OEDEMA 1
210 FEELING ABNORMAL 1
211 FLATULENCE 1
212 FLUID RETENTION 1
213 FOCAL NODULAR HYPERPLASIA 1
214 FULL BLOOD COUNT ABNORMAL 1
215 FUNGAEMIA 1
216 GASTRIC FISTULA 1
217 GASTRIC INFECTION 1
218 GASTRIC PERFORATION 1
219 GASTROINTESTINAL OEDEMA 1
220 GASTROOESOPHAGEAL REFLUX DISEASE 1
221 GLOMERULONEPHRITIS CHRONIC 1
222 GLOSSITIS 1
223 GOUT 1
224 HAEMATOTOXICITY 1
225 HAEMOTHORAX 1
226 HEPATIC CYST 1
227 HEPATIC ENCEPHALOPATHY 1
228 HEPATIC LESION 1
229 HEPATIC NECROSIS 1
230 HEPATIC STEATOSIS 1
231 HEPATOMEGALY 1
232 HEPATOSPLENOMEGALY 1
233 HYPERCALCAEMIA 1
234 HYPERPARATHYROIDISM SECONDARY 1
235 HYPERSOMNIA 1
236 HYPERTHYROIDISM 1
237 HYPERTRANSAMINASAEMIA 1
238 HYPOAESTHESIA 1
239 HYPOKALAEMIA 1
240 HYPONATRAEMIA 1
241 ILEUS 1
242 ILEUS PARALYTIC 1
243 IMMUNOGLOBULINS DECREASED 1
244 IMPAIRED QUALITY OF LIFE 1
245 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
246 INCORRECT DOSE ADMINISTERED 1
247 INFLUENZA 1
248 INFUSION SITE EXTRAVASATION 1
249 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1
250 INTESTINAL OBSTRUCTION 1
251 KLEBSIELLA INFECTION 1
252 LIP DRY 1
253 LIVER FUNCTION TEST ABNORMAL 1
254 LUNG INFILTRATION 1
255 LYMPHADENOPATHY 1
256 MALAISE 1
257 MALIGNANT MELANOMA 1
258 MENINGITIS 1
259 MENTAL STATUS CHANGES 1
260 MINIMAL RESIDUAL DISEASE 1
261 MUSCLE TIGHTNESS 1
262 MUSCULAR WEAKNESS 1
263 MYELODYSPLASTIC SYNDROME 1
264 MYELOSUPPRESSION 1
265 NASOPHARYNGITIS 1
266 NEPHRITIC SYNDROME 1
267 NEPHROGENIC ANAEMIA 1
268 NEPHROPATHY TOXIC 1
269 NERVOUS SYSTEM DISORDER 1
270 NEUROPSYCHOLOGICAL SYMPTOMS 1
271 NEUTROPENIC INFECTION 1
272 NEUTROPENIC SEPSIS 1
273 NIGHT SWEATS 1
274 NODULE 1
275 NOROVIRUS INFECTION 1
276 OCULAR HYPERAEMIA 1
277 ORAL MUCOSAL BLISTERING 1
278 ORAL PAIN 1
279 PALPITATIONS 1
280 PANIC ATTACK 1
281 PARAINFLUENZAE VIRUS INFECTION 1
282 PERICARDITIS 1
283 PERIPHERAL SENSORY NEUROPATHY 1
284 PLEURISY 1
285 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
286 PNEUMOMEDIASTINUM 1
287 PNEUMONIA ASPIRATION 1
288 PNEUMONIA VIRAL 1
289 POLYMYALGIA RHEUMATICA 1
290 PRODUCT COMMUNICATION ISSUE 1
291 PRODUCT DOSE OMISSION ISSUE 1
292 PRODUCT PRESCRIBING ISSUE 1
293 PRODUCTIVE COUGH 1
294 PROSTATE CANCER 1
295 PROTEINURIA 1
296 PSEUDOMONAS INFECTION 1
297 PULMONARY MASS 1
298 PURPURA 1
299 RADICULOPATHY 1
300 RASH ERYTHEMATOUS 1
301 RED BLOOD CELL COUNT DECREASED 1
302 RENAL HAEMATOMA 1
303 RENAL TUBULAR NECROSIS 1
304 RESPIRATORY DISORDER 1
305 RESPIRATORY DISTRESS 1
306 RETICULOCYTOPENIA 1
307 ROAD TRAFFIC ACCIDENT 1
308 SCROTAL SWELLING 1
309 SECOND PRIMARY MALIGNANCY 1
310 SECRETION DISCHARGE 1
311 SINUSITIS 1
312 SKIN DISCOLOURATION 1
313 SKIN DISORDER 1
314 SKIN INFECTION 1
315 SKIN MASS 1
316 SKIN REACTION 1
317 SMALL INTESTINAL OBSTRUCTION 1
318 SQUAMOUS CELL CARCINOMA 1
319 TELANGIECTASIA 1
320 TEMPERATURE INTOLERANCE 1
321 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
322 THERAPEUTIC RESPONSE DECREASED 1
323 THERAPEUTIC RESPONSE UNEXPECTED 1
324 THERAPY INTERRUPTED 1
325 THERAPY NON-RESPONDER 1
326 THERAPY PARTIAL RESPONDER 1
327 THERMAL BURN 1
328 THINKING ABNORMAL 1
329 TOOTH INFECTION 1
330 TRANSAMINASES ABNORMAL 1
331 TRANSAMINASES INCREASED 1
332 TRANSIENT HEPATIC ATTENUATION DIFFERENCES 1
333 VENOUS THROMBOSIS 1